Period 1 (2016–2018) (N = 49) | Period 2 (2019–2021) (N = 25) | P-value | Hospital-onset | Community-onset | P-value | ||
---|---|---|---|---|---|---|---|
(N = 52) | Healthcare-associated (N = 19) | Community-acquired (N = 3) | |||||
SCCmec type | |||||||
SCCmec I (n = 2) | 1 (2.0) | 1 (1.0) | > 0.99 | 1 (1.9) | 1 (5.3) | 0 (0.0) | 0.509 |
SCCmec II (n = 16) | 13 (26.5) | 3 (12.0) | 0.151 | 14 (26.9) | 2 (10.5) | 0 (0.0) | 0.125 |
SCCmec IV (n = 56) | 35 (71.4) | 21 (84.0) | 0.233 | 37 (71.2) | 16 (84.2) | 3 (100.0) | 0.238 |
ST groups | |||||||
ST1 group a (n = 4) | 3 (6.1) | 1 (4.0) | > 0.99 | 4 (7.7) | 0 (0.0) | 0 (0.0) | 0.311 |
ST5 group b (n = 14) | 11 (22.4) | 3 (12.0) | 0.358 | 13 (25.0) | 1 (5.3) | 0 (0.0) | 0.052 |
ST72 group c (n = 50) | 31 (63.3) | 19 (76.0) | 0.268 | 31 (59.6) | 17 (89.5) | 2 (66.7) | 0.031 |
Others (n = 6) | 4 (8.2) d | 2 (8.0) e | > 0.99 | 4 (7.7) f | 1 (5.3) g | 1 (33.3) h | > 0.99 |